The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis
Open accessAbstract
Myasthenia gravis (MG) is associated with ectopic germinal centers in the thymus. Thymectomy and glucocorticoids are the main treatments but they induce operative risks and side effects, respectively. The aim of this study was to propose new therapies more efficient for MG. We hypothesized that molecules dysregulated in MG thymus and normalized by glucocorticoids may play a key role in thymic pathogenesis. Using gene chip analysis, we identified 88 genes complying with these criteria, the most remarkable being the B-cell chemoattractant (CXCL13). Its expression was increased in thymus and sera of glucocorticoid-untreated patients and decreased in response to treatment in correlation with clinical improvement. Normal B cells were actively chemoattracted by thymic extracts from glucocorticoid-untreated patients, an effect inhibited by anti-CXCL13 antibodies. In the thymus, CXCL13 was preferentially produced by epithelial cells and overproduced by epithelial cells from MG patients. Altogether, our results suggest that a high CXCL13 production by epithelial cells could be responsible for germinal center formation in MG thymus. Furthermore, they show that this gene is a main target of corticotherapy. Thus, new therapies targeting CXCL13 could be of interest for MG and other autoimmune diseases characterized by ectopic germinal center formation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Qin, S., Rottman, J. B., Myers, P., Kassam, N., Weinblatt, M., Loetscher, M., Koch, A. E., Moser, B., & Mackay, C. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1422 · Cited by 1,359
Cited by
Myasthenia gravis: A comprehensive review of immune dysregulation and etiological mechanisms
Berrih-Aknin, S., & Le Panse, R. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.12.011 · Cited by 383
Self-citationCXCL13 and Its Receptor CXCR5 in Cancer: Inflammation, Immune Response, and Beyond
Kazanietz, M. G., Durando, M., & Cooke, M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00471 · Cited by 356
The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes
Marx, A., Pfister, F., Schalke, B., Saruhan-Direskeneli, G., Melms, A., & Ströbel, P. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.03.007 · Cited by 351
van de Pavert, S. A., Olivier, B. J., Goverse, G., Vondenhoff, M. F., Greuter, M., Beke, P., Kusser, K., Höpken, U. E., Lipp, M., Niederreither, K., et al. (2009) · Nature Immunology · doi:10.1038/ni.1789 · Cited by 312
B cells and multiple sclerosis
Franciotta, D., Salvetti, M., Lolli, F., Serafini, B., & Aloisi, F. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70192-3 · Cited by 287
Metadata
- Authors
- Meraouna, A., Cizeron-Clairac, G., Panse, R. L., Bismuth, J., Truffault, F., Tallaksen, C., & Berrih-Aknin, S.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2006-07-15
- Volume
- 108
- Issue
- 2
- Pages
- 432-440
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2046251896
- Cited by
- 172
- References
- 1
- FWCI
- 4.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis. https://app.cochat.ai/papers/10.1182/blood-2005-06-2383
- The paper
- Meraouna, A., Cizeron-Clairac, G., Panse, R. L., Bismuth, J., Truffault, F., Tallaksen, C., & Berrih-Aknin, S. (2006). The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis. Blood. https://doi.org/10.1182/blood-2005-06-2383
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.